- Thompson Street Capital Partners, a private equity firm, has acquired Vector Laboratories, the Protein Detection business unit of Maravai Lifesciences Holdings Inc MRVI.
- The financial terms of the deal were not disclosed.
- Vector Laboratories manufactures labeling and visual detection reagents for life science researchers doing tissue-based protein detection and characterization.
- Price Action: MRVI shares closed 2.50% lower at $58.61 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
